University of Limerick
Browse
Benedictis_2024_Secondary.pdf (7.32 MB)

Secondary modification of S100B influences anti amyloid-β aggregation activity and Alzheimer’s disease pathology

Download (7.32 MB)
journal contribution
posted on 2024-02-06, 18:29 authored by Romina Coelho, Chiara DeBenedictisChiara DeBenedictis, Ann Katrin SauerAnn Katrin Sauer, António J. Figueira, Hélio Faustino, Andreas GrabruckerAndreas Grabrucker, Cláudio M Gomes

Proteinaceous aggregates accumulate in neurodegenerative diseases such as Alzheimer’s Disease (AD), inducing cellular defense mechanisms and altering the redox status. S100 pro-nflammatory cytokines, particularly S100B, are activated during AD, but recent findings reveal an unconventional molecular chaperone role for S100B in hindering Aβ aggregation and toxicity. Thissuggests a potential protective role for S100B at the onset of Aβ proteotoxicity, occurring in a complex biochemical environment prone to oxidative damage. Herein, we report an investigation in which extracellular oxidative conditions are mimicked to test if the susceptibility of S100B to oxidation influences its protective activities. Resorting to mild oxidation of S100B, we observed methionine oxidation as inferred from mass spectrometry, but no cysteine-mediated crosslinking. Structural analysis showed that the folding, structure, and stability of oxidized S100B were not affected, and nor was its quaternary structure. However, studies on Aβ aggregation kinetics indicated that oxidized S100B was more effective in preventing aggregation, potentially linked to the oxidation of Met residues within the S100:Aβ binding cleft that favors interactions. Using a cell culture model to analyze the S100B functions in a highly oxidative milieu, as in AD, we observed that Aβ toxicity is rescued by the co-administration of oxidized S100B to a greater extent than by S100B. Additionally, results suggest a disrupted positive feedback loop involving S100B which is caused by its oxidation, leading to the downstream regulation of IL-17 and IFN-α2 expression as mediated by S100B.


Funding

The role of secondary of S100B in protein aggregation and its influence on Alzheimers disease pathology.

Fundação para a Ciência e Tecnologia

Find out more...

Biosystems and Integrative Sciences Institute

Fundação para a Ciência e Tecnologia

Find out more...

Biosystems and Integrative Sciences Institute

Fundação para a Ciência e Tecnologia

Find out more...

Twinning for excellence in biophysics of protein interactions and self-assembly (Twin2PIPSA)

Innovate UK

Find out more...

History

Publication

International Journal of Molecular Sciences, 2024, 25, 1787

Publisher

MDPI

Other Funding information

This study was funded by the Fundação para a Ciência e Tecnologia (Portugal) through Ph.D. fellowships SFRH/PD/BD/142897/2018 (to RC) and BD/06393/2021 (to AF) and center grants UIDB/04046/2020 (https://doi.org/10.54499/UIDB/04046/2020 accessed on 24 January 2024) and UIDP/MULTI/04046/2020 (https://doi.org/10.54499/UIDP/04046/2020 accessed on 24 January 2024) (BioISI). This study was partly funded by the European Union (TWIN2PIPSA–Twinning for excellence in biophysics of protein interactions and self-assembly, GA 101079147). All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations or those of the publisher, the editors, or the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Also affiliated with

  • Bernal Institute
  • Health Research Institute (HRI)

Sustainable development goals

  • (3) Good Health and Well-being

Department or School

  • Biological Sciences

Usage metrics

    University of Limerick

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC